0001209191-20-010544.txt : 20200219
0001209191-20-010544.hdr.sgml : 20200219
20200219163504
ACCESSION NUMBER: 0001209191-20-010544
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200217
FILED AS OF DATE: 20200219
DATE AS OF CHANGE: 20200219
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEIDEN JEFFREY M
CENTRAL INDEX KEY: 0001242825
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 20630305
MAIL ADDRESS:
STREET 1: 40 LANDSDOWNE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-02-17
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001242825
LEIDEN JEFFREY M
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
1
0
0
CEO & President
Common Stock
2020-02-17
4
F
0
9314
241.50
D
123226
D
Common Stock
2020-02-18
4
S
0
1680
241.78
D
121546
D
Common Stock
2020-02-18
4
S
0
4241
242.61
D
117305
D
Common Stock
2020-02-18
4
S
0
1971
243.65
D
115334
D
Common Stock
2020-02-18
4
S
0
2030
244.87
D
113304
D
Common Stock
2020-02-18
4
S
0
1763
245.66
D
111541
D
Common Stock
440
I
401(k)
Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $241.78 (range $241.20 to $242.19).
Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $242.61 (range $242.23 to $243.19).
Open market sales reported on this line occurred at a weighted average price of $243.65 (range $243.24 to $244.23).
Open market sales reported on this line occurred at a weighted average price of $244.87 (range $244.30 to $245.26).
Open market sales reported on this line occurred at a weighted average price of $245.66 (range $245.32 to $245.92).
/s/ Omar White, Attorney-in-Fact
2020-02-19